From: Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients
Parameters | Unadjusted | Model 1a | Model 2b |
---|---|---|---|
Phosphated (mg/dL) | |||
0-3.7 | 1 (reference) | 1 (reference) | 1 (reference) |
3.7-4.2 | 2.04 (1.13-3.7)* | 1.53 (0.77-3.03) | 1.81 (0.86-3.81) |
>4.2 | 4.56 (2.59-8.03)* | 2.38 (1.21-4.68)* | 1.98 (0.92-4.28) |
PTHe (pg/mL) | |||
1-42 | 1 (reference) | 1 (reference) | 1 (reference) |
42-65 | 12.7 (1.65-97.5)* | 5.73 (0.7-46.6) | 5.66 (0.69-46.2) |
65-105 | 13.2 (1.74-99.9)* | 8.6 (1.09-67.7)* | 8.77 (1.12-68.8)* |
>105 | 51.4 (7.08-374)* | 20.8 (2.75-158)* | 16.5 (2.18-125)* |
25-OH-Df (ng/mL) | |||
>30 | 1 (reference) | 1 (reference) | 1 (reference) |
15-30 | 1.84 (0.78-4.34) | 3.64 (0.86-15.4) | 3.33 (0.78-14.1) |
<15 | 4.07 (1.67-9.92)* | 6.82 (1.52-30.6)* | 5.73 (1.27-26)* |